AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

SOLIGENIX, INC. Director's Dealing 2009

Jul 2, 2009

35119_dirs_2009-07-02_ed592a40-f7ad-4256-8a08-2d2e6e8861b4.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DOR.OB)
CIK: 0000812796
Period of Report: 2009-01-20

Reporting Person: Biotex Pharma Investments, LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, Par Value $0.001 per share	20000000	Direct